Table: begin end state 1 8 cytoplasmic 9 35 transmembrane 36 50 non-cytoplasmic 51 71 transmembrane 72 77 cytoplasmic 78 104 transmembrane 105 106 non-cytoplasmic 107 126 transmembrane 127 137 cytoplasmic 138 159 transmembrane 160 169 non-cytoplasmic 170 192 transmembrane 193 211 cytoplasmic 212 234 transmembrane 235 239 non-cytoplasmic 240 256 transmembrane 257 270 cytoplasmic 271 293 transmembrane 294 312 non-cytoplasmic 313 343 transmembrane 344 354 cytoplasmic 355 378 transmembrane 379 398 non-cytoplasmic 399 424 transmembrane 425 427 cytoplasmic
Input: >AZOBR_RS26625 FitnessBrowser__azobra:AZOBR_RS26625 VTIVIFVGSLLGAMALGLPIAFALIVSGLALMAFMGMLDPQIVVQSMWDGANSFPLLAVP FFMLAGEFMNAGGMSRRIIAMAMAWVGHLRGGLGFVAVFAAILMASLSGSAVADTAALAS ILLPMMRQAGYDIHRSGGLIAAGGIIAPVIPPSIGMILYGVAGQVSITKLFLAGIVPGIM MGVALLITWWWLARREILTTPPKVPLRERLRLTADAFWAMLLPVVIIGGLKTGVFTPTEA AVVAAVYAMFVGLVIYRELRIADLYGLMLSAAKTTAVVMFLVAAAGISAWLITASNIPAQ LADLLAPVMDNRLLLMLALMVIVLIVGTALDFAPTILLMVPVLMPIIKQAGIDPVYFGVL FIMNNAIGLITPPVGTVLNVVCGVGRMSMSNLMKGVGPFLLAQTAVLFLLVLFPELVMAP LAWFTAR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server